Myotonic Dystrophy clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
Building on previous work of the Myotonic Dystrophy Clinical Research Network (DMCRN), the present study seeks to overcome insufficient data on natural history; lack of reliable biomarkers; and incomplete characterization and limited biological understanding of the phenotypic heterogeneity of Myotonic Dystrophy 1 by examining strategies to improve the reliability by making further refinements in our sample collection and analysis procedures by developing strategies for managing patient heterogeneity going forward. Funding Source- FDA OOPD
La Jolla, California and other locations
Our lead scientists for Myotonic Dystrophy research studies include Chamindra Konersman, MD.